Bio-Rad Laboratories - 23 Year Stock Split History | BIO.B

Stock split history for Bio-Rad Laboratories since 1999. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Bio-Rad Laboratories Annual Stock Splits
Bio-Rad Laboratories Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.433B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $153.119B 9.29
GSK (GSK) United Kingdom $59.709B 7.17
Biohaven Pharmaceutical Holding (BHVN) United States $10.856B 0.00
QIAGEN (QGEN) Netherlands $9.360B 15.67
Ginkgo Bioworks Holdings (DNA) United States $5.587B 0.00
Arcus Biosciences (RCUS) United States $1.842B 35.96
Myovant Sciences (MYOV) United Kingdom $1.684B 0.00
Emergent Biosolutions (EBS) United States $1.036B 6.01
ADC Therapeutics SA (ADCT) Switzerland $0.376B 0.00
Zymeworks (ZYME) Canada $0.336B 0.00
Enzo Biochem (ENZ) United States $0.107B 0.00
Gelesis Holdings (GLS) United States $0.078B 0.00
SQZ Biotechnologies (SQZ) United States $0.065B 0.00
Ambrx Biopharma (AMAM) United States $0.042B 0.00